Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L T Chen

Showing results (161-170 of 192) with videos related to

Pageof 20
Sort By:
British Journal of Cancer|July 1, 2004
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancerY Chao, K H Yeh, C J Chang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 16, 2018
Dialysis Provider and Outcomes among United States Veterans Who Transition to DialysisElani Streja, Csaba Pal Kovesdy, Melissa Soohoo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 16, 2017
Transition of care from pre-dialysis prelude to renal replacement therapy: the blueprints of emerging research in advanced chronic kidney diseaseKamyar Kalantar-Zadeh, Csaba P Kovesdy, Elani Streja, et al.
The Journal of Pathology|December 15, 2006
Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expressionS-H Kuo, L-T Chen, M-S Wu, et al.
Blood Cancer Journal|October 11, 2014
Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphomaF Liao, Y-C Hsu, S-H Kuo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2013
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinomaA C Roy, S R Park, D Cunningham, et al.
Oncogene|March 15, 2011
Identification of salt-inducible kinase 3 as a novel tumor antigen associated with tumorigenesis of ovarian cancerS Charoenfuprasert, Y-Y Yang, Y-C Lee, et al.
British Journal of Cancer|September 3, 2010
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patientsT-S Yang, S-N Lu, Y Chao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2018
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4)N Boku, M-H Ryu, K Kato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 10, 2020
JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusionsT Yoshino, G Pentheroudakis, S Mishima, et al.
Pageof 20

Showing results (161-170 of 192) with videos related to

Sort By:
Pageof 20
British Journal of Cancer|July 1, 2004
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancerY Chao, K H Yeh, C J Chang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 16, 2018
Dialysis Provider and Outcomes among United States Veterans Who Transition to DialysisElani Streja, Csaba Pal Kovesdy, Melissa Soohoo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 16, 2017
Transition of care from pre-dialysis prelude to renal replacement therapy: the blueprints of emerging research in advanced chronic kidney diseaseKamyar Kalantar-Zadeh, Csaba P Kovesdy, Elani Streja, et al.
The Journal of Pathology|December 15, 2006
Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expressionS-H Kuo, L-T Chen, M-S Wu, et al.
Blood Cancer Journal|October 11, 2014
Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphomaF Liao, Y-C Hsu, S-H Kuo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2013
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinomaA C Roy, S R Park, D Cunningham, et al.
Oncogene|March 15, 2011
Identification of salt-inducible kinase 3 as a novel tumor antigen associated with tumorigenesis of ovarian cancerS Charoenfuprasert, Y-Y Yang, Y-C Lee, et al.
British Journal of Cancer|September 3, 2010
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patientsT-S Yang, S-N Lu, Y Chao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2018
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4)N Boku, M-H Ryu, K Kato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 10, 2020
JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusionsT Yoshino, G Pentheroudakis, S Mishima, et al.
Pageof 20